Prevalence and Incidence of Arthrogryposis multiplex congenita -- pulmonary hypoplasia

Arthrogryposis multiplex congenita -- pulmonary hypoplasia: Rare Disease

Arthrogryposis multiplex congenita -- pulmonary hypoplasia is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This means that Arthrogryposis multiplex congenita -- pulmonary hypoplasia, or a subtype of Arthrogryposis multiplex congenita -- pulmonary hypoplasia, affects less than 200,000 people in the US population.

Ophanet, who are a consortium of European partners, currently defines a condition rare when if affects 1 person per 2,000. They list Arthrogryposis multiplex congenita -- pulmonary hypoplasia as a "rare disease". More information about Arthrogryposis multiplex congenita -- pulmonary hypoplasia is available from Orphanet

About prevalence and incidence statistics:

The term 'prevalence' of Arthrogryposis multiplex congenita -- pulmonary hypoplasia usually refers to the estimated population of people who are managing Arthrogryposis multiplex congenita -- pulmonary hypoplasia at any given time. The term 'incidence' of Arthrogryposis multiplex congenita -- pulmonary hypoplasia refers to the annual diagnosis rate, or the number of new cases of Arthrogryposis multiplex congenita -- pulmonary hypoplasia diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.

Search Specialists by State and City